Among the impediments for the development of therapies to halt chronic diseases of aging and Alzheimer's disease, the need to integrate scientific, population-level, and clinical information is gaining distinction. In an era of declining biomedical research resources, international public health research funders are joining together in a growing chorus emphasizing the call for "translational knowledge" that spans from "bench to bedside". These governmental and non-governmental agencies are actively promoting and fostering international collaborations as a means to leverage resources to combat major public health problems. This is sound public health policy. The strategy is derived from a well-established tradition of international cooperation in other areas of biomedical research, mostly in infectious and other acute diseases. Yet, the application of these methods for chronic diseases such as Alzheimer's disease requires a recalibration of tactics along three planes. The first is the recognition to build upon ongoing projects and integrate existing resources to establish an International Database for Longitudinal Studies on Aging and Dementia (IDAD) [1, 2] . The second includes greater harmonization among the multitude of ongoing international collaborative research and data-sharing initiatives. The third is the formulation of standardized international data-sharing guidelines, including solutions to provide prospective and retrospective volunteer informed consent, to expand these endeavors. These shifts will enable better methods that may someday identify asymptomatic people at elevated risk for chronic brain disorders that effect cognition, motor functions, or mood [3] .
There are many excellent ongoing efforts to organize multiple users, institutions and nations to support big data development, such as the National Alzheimer's Coordinating Center, Alzheimer's Disease Neuroimaging Initiative, European Medical Informatics Framework, Global Alzheimer Association Interactive Network, Dominantly Inherited Alzheimer Network, Alzheimer Prevention Initiative, and European Commission Joint Programming Initiative. However, the macro-level challenge of achieving seamless integration of data, information, and knowledge remains beyond the intended mission of these projects. In order to usher in the era of big data for aging and dementia research, three key mission parameters need to be addressed:
1. Magnitude and multiple domains of data: With few exceptions, most ongoing efforts involve relatively small sample sizes designed to address highly focused areas of research questions. These datasets include specific, often nonoverlapping, domains of data that serve the special needs of particular data consumer clientele [e.g., genetic, imaging, epidemiology, etc.]. 2. Harmonization: Linkage among ongoing efforts, networks, or databases has started, but issues of data sharing, data merging, and privacy concerns/volunteer informed consent need to be strengthened, expanded, and reviewed. 3. Funding: The most critical problem is lack of adequate and sustained funding to support the data management beyond the life cycle of a grant. The international big data initiative must identify new and/or hybrid financing mechanisms to support massive global enterprise. The effort to launch a massive international enterprise, such as IDAD, will require the support and cooperation of not only the worldwide scientific community, but also an international body of policy makers. Without any doubt, this undertaking will be: a) extremely difficult (with a large array of scientific, technical, administrative, and financial barriers that have to be navigated), b) extremely costly (the project will need to explore novel models for financing), and c) extremely time-intensive.
The first step towards the creation of IDAD and the process of formulating international guidelines to harmonize datasharing among collaborative research networks will require a thorough assessment of all existing databases, cohorts, ongoing longitudinal studies, and collaborative research networks. Thus, this call-to-action outlines an essential first step to assemble a comprehensive annotated inventory of all the relevant information on available resources or current efforts. The project of establishing a single location for citation and a process for documenting all databases-resources will be an interactive process between the worldwide scientific community and Alzheimer's & Dementia.
Global investigators are invited to participate in assembling and evaluating the proposed inventory of resources. Participation in this project entails providing input to the deliberations of virtual workgroups. Potential contributions may be considered towards the composition of an eventual big data special issue in Alzheimer's & Dementia and include topics related to computational and analytical approaches to knowledge extraction from large, complex datasets.
The special issue will aim to provide a set of seminal articles on the array of challenges confronted by various groups in their efforts to establish a multi-site collaborative research network, harmonize data sharing rules, and manage (governance/financing) of big databases as shared global resources. This pending special issue will contain not only a wide spectrum of thought-provoking perspectives on the rationale, utility and challenges of establishing a comprehensive multi-purpose database (as a shared international research and development resource), but also it will assemble a comprehensive inventory of all ongoing, cohorts, longitudinal studies/databases, and collaborative research networks. An initial listing of the pending comprehensive inventory can be found online in Supplementary Table 1 Alzheimer's & Dementia solicits suggestions from the wider scientific community of any additional databases, cohorts, or ongoing studies that should be included in the proposed comprehensive inventory. Readers are invited to suggest additional studies, cohorts, collaborative networks, public and private partnerships, or databases that should be considered for inclusion in the listing of the final version of this catalog. Once the initial survey is complete, periodic updates and amendments to the comprehensive catalog will be made with the addition of new studies or related efforts. Readers are also invited to share their thoughts about any aspect of this project, the special issue, and volunteers willing to support this venture.
The specific goals will be to survey and review all major data series that can be combined in standardized formats, codified and made accessible for truly international comparative purposes. There is also a need to assess the feasibility of integrating, harmonizing, and standardizing (whenever possible) all ongoing longitudinal databases comprising different domains of measurements (e.g., behavioral, biological, life-style, genetics, neuroimaging, biomarker, and other healthcare or services information). Subsequently, the volunteer workgroup will need to evaluate various models for the governance, financing and, harmonizing of IDAD.
The four questions requiring assistance during the initial phase of this endeavor are:
1. What are some of the key additional longitudinal studies, cohorts, databases, collaborative research networks, or other research consortia that should be included in the comprehensive inventory? (Supplementary Table 1 
